Prompt but inefficient: nicotine differentially modulates discrete components of attention.

What Was Tested

Researchers studied Therapeutic nicotine (patch, non-peptide) in this randomized controlled trial publication.

Using an unspeeded, accuracy-based test, the CombiTVA paradigm, the researchers examined whether nicotine enhances attention when it is measured independently of motor processing.

Why It Was Studied

Since very few studies have assessed effects of nicotine on visual attention using measures that are uncontaminated by motoric effects, nicotine's attentional effects may, at least partially, be due to speeding of motor function.

Who Took Part

The age groups tagged for this paper are young adults and adults, both men and women.

How the Study Was Run

In design terms this was a randomized, double-blind, placebo-controlled and crossover study.

Because people in this Therapeutic nicotine (patch, non-peptide) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Neither the participants nor the staff measuring them knew who was on Therapeutic nicotine (patch, non-peptide), so expectations could not easily colour the readings.

Some participants received a placebo instead of Therapeutic nicotine (patch, non-peptide), giving a reference point.

Each person switched between Therapeutic nicotine (patch, non-peptide) and the comparison at some point, usually with a gap in between.

The researchers modelled data with a computational theory of visual attention (TVA; Bundesen 1990) so as to derive independent estimates of several distinct components of attention from performance of the single task: threshold of visual perception, perceptual processing speed, visual short-term memory storage capacity and top-down controlled selectivity.

Chronic effects of nicotine were investigated in 24 age- and education-matched minimally deprived smokers.

What Was Measured

Since very few studies have assessed effects of nicotine on visual attention using measures that are uncontaminated by motoric effects, nicotine's attentional effects may, at least partially, be due to speeding of motor function.

PubMed files the paper under topics including Attention, Cognition, Memory, Short-Term, Models, Biological, Nicotine, Nicotinic Agonists and Smoking.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Therapeutic nicotine (patch, non-peptide).

Results are reported in around 4 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2011 (Psychopharmacology), a journal based in Germany.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.